EGFR and neoplasm: In total, 73 tumor-specific somatic mutations were detected in 16 genes from 39 patients, including genes with recurrent somatic alterations, such as TP53 (62.3%), PIK3CA (17.0%), EGFR (7.5%), and PTCH1 (5.7%) (Figure S1).